Han Chow Chua

Han Chow Chua

Auto-generated profile, based on publicly available information

Han Chow Chua

The University of Sydney

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

24 April 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
HCH. C. Chua
H. C. Chua
MWM. Wulf
M. Wulf
CWC. Weidling
C. Weidling
LRL. P. Rasmussen
L. P. Rasmussen
SPS. A. Pless
S. A. Pless
The sodium leak channel (NALCN) is essential for survival in mammals: NALCN mutations are life-threatening in humans and knockout is lethal in mice. However, the basic functional and pharmacological properties of NALCN have remained elusive. Here, we found that robust function of NALCN in heterologous systems requires co-expression of UNC79, UNC80, and FAM155A. The resulting NALCN channel complex is constitutively active and conducts monovalent cations but is blocked by physiological concentrations of extracellular divalent cations. Our data support the notion that NALCN is directly responsible for the increased excitability observed in a variety of neurons in reduced extracellular Ca2+. Despite the smaller number of voltage-sensing residues in NALCN, the constitutive activity is modulated by voltage, suggesting that voltage-sensing domains can give rise to a broader range of gating phenotypes than previously anticipated. Our work points toward formerly unknown contributions of NALCN to neuronal excitability and opens avenues for pharmacological targeting.

29 December 2025 in British Journal of Pharmacology
Verified
Journal Article
Open access
SASteve Alexander
Steve Alexander
JSJörg Striessnig
Jörg Striessnig
AGAlasdair J. Gibb
Alasdair J. Gibb
AMAlistair A. Mathie
Alistair A. Mathie
EVEmma L. Veale
Emma L. Veale
Michael ZhuMichael Zhu
Michael Zhu
The Concise Guide to Pharmacology 2025/26 marks the seventh edition in this series of biennial publications in the British Journal of Pharmacology. Presented in landscape format, the guide provides a comparative overview of the pharmacology of drug target families. The concise nature of the Concise Guide refers to the style of presentation, being clear, accessible, and well‐structured, rather than the scope of the content, which spans approximately 500 pages. The Concise Guide summarises the key pharmacological properties of around 1900 human drug targets, and nearly 7000 interactions, involving around 4400 ligands. While the content is a substantially condensed version of the more detailed information and links available at the www.guidetopharmacology.org website, the printed guide serves as a permanent, citable, point‐in‐time record, that remains stable despite ongoing updates to the online database. The full contents of this publication can be found at https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.70231 . The Concise Guides provide expert‐curated recommendations of ‘Gold Standard’ selective pharmacological tools, available either commercially or as donations, which enable the identification of individual drug targets or families of drug targets. While the Concise Guide offers a more streamlined overview, more comprehensive information, including detailed pharmacological profiles and links to multiple online databases, is available through the Guide to Pharmacology website. The 2025/26 edition of the Concise Guide is based on material current as of mid‐2025, and supersedes all previous editions, including the 2023/24 Guide, and earlier Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC‐IUPHAR), and as such provides official IUPHAR classification and nomenclature for human drug targets, where applicable. Ion channels are one of the six major pharmacological targets into which the Guide is divided, with the others being: G protein‐coupled receptors, nuclear hormone receptors, catalytic receptors, enzymes and transporters. Each section includes nomenclature guidance, concise summaries, information of the best available pharmacological tools, key references, and suggestions for further reading.

22 June 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HCHan Chow Chua
Han Chow Chua
ECEmilie T. H. Christensen
Emilie T. H. Christensen
KHKirsten Hoestgaard-Jensen
Kirsten Hoestgaard-Jensen
LHLeonny Y. Hartiadi
Leonny Y. Hartiadi
IRIqbal Ramzan
Iqbal Ramzan
MCMary Chebib
Mary Chebib
Extracts of the pepper plant kava (Piper methysticum) are effective in alleviating anxiety in clinical trials. Despite the long-standing therapeutic interest in kava, the molecular target(s) of the pharmacologically active constituents, kavalactones have not been established. γ-Aminobutyric acid type A receptors (GABAARs) are assumed to be the in vivo molecular target of kavalactones based on data from binding assays, but evidence in support of a direct interaction between kavalactones and GABAARs is scarce and equivocal. In this study, we characterised the functional properties of the major anxiolytic kavalactone, kavain at human recombinant α1β2, β2γ2L, αxβ2γ2L (x = 1, 2, 3 and 5), α1βxγ2L (x = 1, 2 and 3) and α4β2δ GABAARs expressed in Xenopus oocytes using the two-electrode voltage clamp technique. We found that kavain positively modulated all receptors regardless of the subunit composition, but the degree of enhancement was greater at α4β2δ than at α1β2γ2L GABAARs. The modulatory effect of kavain was unaffected by flumazenil, indicating that kavain did not enhance GABAARs via the classical benzodiazepine binding site. The β3N265M point mutation which has been previously shown to profoundly decrease anaesthetic sensitivity, also diminished kavain-mediated potentiation. To our knowledge, this study is the first report of the functional characteristics of a single kavalactone at distinct GABAAR subtypes, and presents the first experimental evidence in support of a direct interaction between a kavalactone and GABAARs.

22 July 2020 in Nature
Verified
Journal Article
Closed access
PDF file
MKMarc Kschonsak
Marc Kschonsak
HCHan Chow Chua
Han Chow Chua
CNCameron L. Noland
Cameron L. Noland
CWClaudia Weidling
Claudia Weidling
TCThomas Clairfeuille
Thomas Clairfeuille
JPJian Payandeh
Jian Payandeh

20 December 2021 in Nature
Verified
Journal Article
Closed access
PDF file
MKMarc Kschonsak
Marc Kschonsak
HCHan Chow Chua
Han Chow Chua
CWClaudia Weidling
Claudia Weidling
NCNourdine Chakouri
Nourdine Chakouri
CNCameron Noland
Cameron Noland
JPJian Payandeh
Jian Payandeh